Journal Article

Time in range: a new parameter to evaluate blood glucose control in patients with diabetes

Puñales, Marcia, Ramalho, Ana Claudia, Reis, Janice Sepúlveda, Krakauer, Marcio, Franco, Denise Reis, Pedrosa, Hermelinda Pedrosa Cordeiro, Miranda, Leonardo Garcia, Vianna, Andre Gustavo Daher, Gabbay, Monica Andrade Lima, Rodacki, Melanie, Pinto, Mauro Scharf, Calliari, Luis Eduardo

2020

Overview

The International Consensus in Time in Range (TIR) was recently released and defined the concept of the time spent in the target range between 70 and 180 mg/dL while reducing time in hypoglycemia, for patients using Continuous Glucose Monitoring (CGM). TIR was validated as an outcome measures for clinical Trials complementing other components of glycemic control like Blood glucose and HbA1c. The challenge is to implement this practice more widely in countries with a limited health public and private budget as it occurs in Brazil. Could CGM be used intermittently? Could self-monitoring blood glucose obtained at different times of the day, with the amount of data high enough be used? More studies should be done, especially cost-effective studies to help understand the possibility of having sensors and include TIR evaluation in clinical practice nationwide.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Blood glucose / Blood glucose tests / Budgets / Care and treatment / Clinical trials / Continuous glucose monitoring / Diabetes / Diabetes mellitus / Diabetes therapy / Diabetics / Disease management / Endocrinology / Glucose / Glucose monitoring / Glycated hemoglobin / Glycosylated hemoglobin / Hemoglobins / Hypoglycemia / Medical economics / Medical screening / Medicine / Medicine & Public Health / Metabolic Diseases / Patient monitoring equipment / Review / Sensors / Time / Time in range